Primary |
Product Used For Unknown Indication |
41.1% |
Drug Use For Unknown Indication |
31.6% |
Pyrexia |
4.0% |
Pain |
3.8% |
Headache |
2.3% |
Intentional Overdose |
2.2% |
Ill-defined Disorder |
1.7% |
Rheumatoid Arthritis |
1.4% |
Arthralgia |
1.2% |
Cancer Pain |
1.1% |
Back Pain |
1.1% |
Depression |
1.1% |
Hypertension |
1.1% |
Suicide Attempt |
1.0% |
Drug Exposure During Pregnancy |
1.0% |
Nasopharyngitis |
0.9% |
Oropharyngeal Pain |
0.9% |
Immunosuppression |
0.8% |
Influenza |
0.8% |
Influenza Like Illness |
0.8% |
|
Overdose |
33.4% |
Toxicity To Various Agents |
9.5% |
Suicide Attempt |
9.1% |
Vomiting |
6.0% |
Hypersensitivity |
5.6% |
Liver Injury |
5.2% |
Renal Failure Acute |
4.3% |
Hepatotoxicity |
4.2% |
Toxic Epidermal Necrolysis |
3.1% |
Renal Failure |
3.0% |
Urticaria |
2.8% |
Intentional Overdose |
2.2% |
Drug Toxicity |
2.0% |
Drug Exposure During Pregnancy |
1.6% |
Stevens-johnson Syndrome |
1.5% |
Multiple Drug Overdose |
1.4% |
Sepsis |
1.3% |
Acute Hepatic Failure |
1.2% |
Hepatic Failure |
1.2% |
Wheezing |
1.2% |
|
Secondary |
Product Used For Unknown Indication |
40.5% |
Drug Use For Unknown Indication |
20.9% |
Pain |
8.5% |
Pyrexia |
4.4% |
Drug Abuse |
3.0% |
Hypertension |
2.8% |
Anaesthesia |
2.6% |
Supplementation Therapy |
1.8% |
Headache |
1.7% |
Analgesic Therapy |
1.7% |
Intentional Overdose |
1.5% |
Rheumatoid Arthritis |
1.4% |
Ill-defined Disorder |
1.3% |
Premedication |
1.3% |
Prophylaxis |
1.2% |
Back Pain |
1.2% |
Toothache |
1.1% |
Thrombosis Prophylaxis |
1.1% |
Suicide Attempt |
1.1% |
Alcohol Withdrawal Syndrome |
1.0% |
|
Overdose |
19.9% |
Suicide Attempt |
12.6% |
Vomiting |
12.5% |
Toxicity To Various Agents |
6.9% |
Toxic Epidermal Necrolysis |
6.1% |
Renal Failure Acute |
4.4% |
Multiple Drug Overdose |
3.5% |
Liver Injury |
3.4% |
Somnolence |
3.4% |
Urticaria |
3.3% |
Stevens-johnson Syndrome |
3.0% |
Thrombocytopenia |
2.7% |
Renal Failure |
2.7% |
Drug Toxicity |
2.6% |
Hepatocellular Injury |
2.6% |
Rhabdomyolysis |
2.5% |
Cytolytic Hepatitis |
2.1% |
Tachycardia |
2.0% |
Tremor |
1.9% |
Weight Decreased |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
26.5% |
Drug Use For Unknown Indication |
21.2% |
Pain |
9.5% |
Rheumatoid Arthritis |
6.8% |
Prophylaxis |
5.9% |
Premedication |
5.2% |
Hypertension |
5.1% |
Crohn's Disease |
2.8% |
Depression |
2.1% |
Nausea |
1.8% |
Diffuse Large B-cell Lymphoma |
1.7% |
Constipation |
1.5% |
Analgesic Therapy |
1.4% |
Pyrexia |
1.4% |
Diabetes Mellitus |
1.3% |
Osteoporosis |
1.3% |
Non-small Cell Lung Cancer |
1.3% |
Hiv Infection |
1.1% |
Breast Cancer |
1.1% |
Headache |
1.0% |
|
Vomiting |
16.4% |
Pyrexia |
7.8% |
Thrombocytopenia |
6.5% |
Weight Decreased |
6.0% |
Renal Failure Acute |
5.5% |
Sepsis |
5.3% |
Pneumonia |
5.0% |
Urinary Tract Infection |
5.0% |
Pulmonary Embolism |
4.1% |
Somnolence |
4.0% |
Tremor |
3.8% |
Rash |
3.8% |
Renal Failure |
3.8% |
Tachycardia |
3.8% |
Death |
3.6% |
Syncope |
3.5% |
Pain |
3.2% |
Weight Increased |
3.1% |
Nausea |
3.0% |
White Blood Cell Count Increased |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
41.1% |
Drug Use For Unknown Indication |
20.5% |
Pain |
5.3% |
Deep Vein Thrombosis |
5.0% |
Metastatic Malignant Melanoma |
4.3% |
Hypertension |
2.3% |
Asthma |
2.0% |
Atrial Fibrillation |
2.0% |
Disseminated Tuberculosis |
2.0% |
Erysipelas |
2.0% |
Escherichia Infection |
2.0% |
Pyrexia |
2.0% |
Combined Immunodeficiency |
1.3% |
Fatigue |
1.3% |
Intervertebral Disc Disorder |
1.3% |
Malaise |
1.3% |
Obsessive-compulsive Disorder |
1.3% |
Epilepsy |
1.0% |
Grand Mal Convulsion |
1.0% |
Hypothyroidism |
1.0% |
|
Drug Interaction |
27.9% |
Pyrexia |
19.1% |
International Normalised Ratio Increased |
10.3% |
Off Label Use |
5.9% |
Metabolic Acidosis |
2.9% |
Rectal Haemorrhage |
2.9% |
Renal Failure |
2.9% |
Renal Impairment |
2.9% |
Sepsis |
2.9% |
Serotonin Syndrome |
2.9% |
Tremor |
2.9% |
Vomiting |
2.9% |
Yellow Skin |
2.9% |
Cardio-respiratory Arrest |
1.5% |
Fall |
1.5% |
Gastrointestinal Haemorrhage |
1.5% |
Hypothermia |
1.5% |
Pain In Extremity |
1.5% |
Rash |
1.5% |
Renal Failure Acute |
1.5% |
|